Arix Bioscience PLC received a notification of major holdings from RTW Investments, LP, a New York-based company, and RTW Biotech Opportunities Operating Ltd, based in St Peter Port, Guernsey. The notification, dated 17/01/2024, indicated that the total positions of the entities subject to the notification obligation amounted to 25.52% of voting rights attached to shares, with 33,023,210 total number of voting rights held in the issuer.
The notification detailed the breakdown of voting rights, with RTW Investments, LP holding 25.52% of voting rights indirectly through financial instruments. The information also revealed that Roderick Wong, through a chain of controlled undertakings, effectively held the voting rights and/or financial instruments.
The completion of the notification took place in London, UK, on 19/01/2024. The announcement was disseminated by EQS Group, and the issuer, Arix Bioscience PLC, is solely responsible for its content. The ISIN for Arix Bioscience PLC is GB00BD045071, and the announcement falls under the category of major shareholding notifications.